Substrate

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Substrate Report for: Eslicarbazepine-acetate

Eslicarbazepine acetate is the acetate ester of licarbazepine. An anticonvulsant, it is used as an adjunctive therapy for epilepsy by inhibiting repeated neuronal firing and stabilizing the inactivated state of voltage-gated sodium channels, thus preventing their return to the activated state during which seizure activity can occur. It is a dibenzoazepine, a carboxamide and a member of ureas.



General
Type: Drug, Pro-Drug, Benzazepin, Carbamate, Acetate, Carboxamide
Chemical_Nomenclature: [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate
Canonical SMILES: CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N
InChI: InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1
InChIKey: QIALRBLEEWJACW-INIZCTEOSA-N
Other name(s): Eslicarbazepine acetate ; BIA 2-093 ; Aptiom ; Zebinix
MW: 296.32
Formula: C17H16N2O3
CAS_number: 236395-14-5
PubChem: 179344
IUPHAR:
Wikipedia:

Target families
Eslicarbazepine-acetate ligand of proteins in family: Carb_B_Chordata, Arylacetamide_deacetylase
No structure

Protein target

References
Search PubMed for references concerning: Eslicarbazepine-acetate
    Title: Role of human AADAC on hydrolysis of eslicarbazepine acetate and effects of AADAC genetic polymorphisms on hydrolase activity
    Hirosawa K, Fukami T, Tashiro K, Sakai Y, Kisui F, Nakano M, Nakajima M
    Ref: Drug Metabolism & Disposition: The Biological Fate of Chemicals, :, 2021 : PubMed

            

    Title: Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers
    Nunes T, Rocha JF, Falcao A, Almeida L, Soares-da-Silva P
    Ref: Epilepsia, 54:108, 2013 : PubMed

            

    Title: A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity
    Shimizu M, Fukami T, Kobayashi Y, Takamiya M, Aoki Y, Nakajima M, Yokoi T
    Ref: Drug Metabolism & Disposition: The Biological Fate of Chemicals, 40:1183, 2012 : PubMed